Elimination of Cervical Cancer in Low-and Middle-Income Countries: Any Alternative to Pap Smear?


  • AE Ubom Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun state, Nigeria
  • CA Adepiti Faculty of Clinical Sciences, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria 2. Gynaecological Oncology Unit, Department of Obstetrics, Gynaecology and Perinatology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria https://orcid.org/0000-0001-7210-6670
  • OC Afon Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria https://orcid.org/0009-0001-9485-9208
  • EG Topcu 1. Safa Hospital, Istanbul, Turkey 2. World Association of Trainees in Obstetrics and Gynecology (WATOG), Paris, France https://orcid.org/0000-0003-1362-6224
  • P Roy 1. Roy’s Multispecialty Hospital, Siliguri, India 2. World Association of Trainees in Obstetrics and Gynecology (WATOG), Paris, France
  • F Ruiloba https://orcid.org/0000-0002-0491-3187




Bhatla, N, Aoki, D, Sharma, DN, Sankaranarayanan, R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obstet. 2021; 155(Suppl. 1): 28– 44. https://doi.org/10.1002/ijgo.13865

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209- 249. https://doi.org/10.3322/caac.21660

Makoni M. HPV vaccine roll-out in Nigeria and Bangladesh. Lancet Oncol. 2023;24(12):P1311-1312. https://doi.org/10.1016/S1470-2045(23)00571-5

World Health Organisation. Nigeria to vaccinate 7.7 million girls against leading cause of cervical cancer. 24 October 2023. Available at: https://www.afro.who.int/countries/nigeria/news/nigeria-vaccinate-77-million-girls-against-leading-cause-cervical-cancer. Accessed 10 December 2023.

Ajenifuja KO, Gage JC, Adepiti CA, Wentzensen N, Eklund C, Reilly M, et al. A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. Int J Gynecol Cancer 2013;23(3). https://doi.org/10.1097/IGC.0b013e318280f395

Olarinoye AO, Shiru MM, Ubom AE, Olabinjo AO, Abdul IF, Ijarotimi OA, et al. Knowledge, Attitude and Uptake of Pap Smear among Female Healthcare Professionals in a Nigerian Teaching Hospital. Annals of Health Research. 2021;7(4):391-402. doi:10.30442/ahr.0704-07-149

Stewart TS, Moodley J, Walter FM. 2018. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Cancer Epidemiol 2018; 53: 81-92. https://doi.org/10.1016/j.canep.2018.01.014

Kamath Mulki A, Withers M. Human Papilloma Virus self-sampling performance in low-and middle-income countries. BMC Women’s Health 2021;21:1-11. https://doi.org/10.1186/s12905-020-01158-4

Desai KT, Ajenifuja KO, Banjo A, Adepiti CA, Novetsky A, Sebag C, et al. Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage. Infect Agents Cancer 2020;15:60. https://doi.org/10.1186/s13027-020-00324-5






Letter To The Editor

Most read articles by the same author(s)